Dr Marcus Auth

Marcus KH Auth is a Consultant Paediatric Gastroenterologist in Alder Hey Children’s Hospital and Honorary Senior Clinical Lecturer at the University of Liverpool. He performed his medical training (MD), academic career (PD) and research in Universities of Frankfurt, Essen and Birmingham and has developed and led the paediatric gastroenterology service in Liverpool. Constantly striving to improve the outcome of children with chronic disease, he published his scientific and clinical expertise in more than 85 peer-reviewed papers, guidelines and book chapters which comprise eosinophilic disorders, polyposis syndromes, inflammatory bowel disease, coeliac disease, interventional endoscopy and liver disease, for which he won international awards. Dr Auth has been BSPGHAN Gastroenterology Chair and EoE working group Chair, and member of BSPGHAN and ESPGHAN eosinophilic gastrointestinal diseases, IBD and polyposis working groups and has had major contributions to national, European and World guidelines on EoE and EGID. Marcus has developed an interest in the role of the gut microbiome, and disease prevention. Currently he leads on a multi-centre trial supported by BSPGHAN/Guts UK on the assessment of faecal volatile compound markers in children with EoE (BioEvocs). He has contributed to prospective studies and guidance on safe medication for children with EoE and IBD. He has won several prestigious medical prizes: Marcus promotes healthy lifestyles, protection of the environment, global climate and peace. GutsUK/BSPGHAN Research Award King's College London - Alex Mowat Award American Association for the Liver Diseases - Paediatric Fellow Research Prize North American Association of Paediatric Gastroenterology - Young Investigator Award European Society for Organ Transplantation - Presentation Prize University Prize for Best Dissertation German Association for Paediatric Gastroenterology and Hepatology - Best Presentation and Publication Prizes Marcus promotes healthy lifestyles, protection of the environment, global climate and humanity.

Inflammatory bowel disease; abdominal pain; irritable bowel; food allergies and food intolerances; coeliac disease; gastro-oesophageal reflux; chronic diarrhoea; constipation; eosinophilic oesophagitis; eosinophilic gastro-intestinal disorders; bowel polyps; liver and gallbladder disease; nutritional problems and feeding disorders; endoscopy; motility disorders; functional gastro-intestinal disorders; diagnostic tests and investigations. Selection from 87 publications: Auth MKH, et al for BSPGHAN IBD working group. Variation in access and prescription of vedolizumab and ustekinumab in paediatric inflammatory bowel disease patients. Arch Dis Child, 2023. Papadopoulou A, Auth MKH, et al. Joint ESPGHAN and NSPGHAN guidelines on Eosinophilic Gastro-Intestinal Disorders, J Ped Gastroent Nutr, 2024. Dias JA, Auth MKH, et al. ESPGHAN Eosinophilic Esophagitis Working Group. Revised ESPGHAN guidelines on management of eosinophilic esophagitis in childhood. J Ped Gastroent Nutr, 2024Dhar A, Auth MKH, ..., et al. British Society of Gastroenterology (BSG) and British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) joint consensus guidelines on the diagnosis and management of eosinophilic oesophagitis in children and adults. Gut 2022. Auth MKH, et al. Improved medical treatment and surgical surveillance of children and adolescents with ulcerative colitis in the United Kingdom. Inflamm Bow Dis 2018. Chan J,…,Auth MKH. Swallowed topical steroid therapy for eosinophilic oesophagitis in children: Practical, evidence-based guidance by the BSPGHAN eosinophilic oesophagitis working group . BMJ Open, in revised submission 2024. Auth MKH, et al. Childhood constipation. British Medical Journal 2012. Auth MK, et al. Investigation of chronic diarrhoea. Pediatr Child Health 2016 Auth MK. The diagnostic accuracy of faecal calprotectin in investigations for suspected inflammatory bowel disease in children. Br J Gen Pract.